It takes two: uptake of carrier screening among male reproductive partners

To describe uptake of carrier screening by male reproductive partners of prenatal and preconception patients.

[1]  I. B. Van den Veyver,et al.  The uptake of pan‐ethnic expanded carrier screening is higher when offered during preconception or early prenatal genetic counseling , 2019, Prenatal diagnosis.

[2]  A. Eisen,et al.  Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review. , 2018, Current oncology.

[3]  J. Tardif,et al.  Experience of carrier couples identified through a population‐based carrier screening pilot program for four founder autosomal recessive diseases in Saguenay–Lac‐Saint‐Jean , 2018, Prenatal diagnosis.

[4]  K. Goddard,et al.  Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing , 2018, Journal of Genetic Counseling.

[5]  B. Stevens,et al.  Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel. , 2017, Obstetrics and gynecology.

[6]  Marian J. Gilmore,et al.  Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing , 2017, Journal of Genetic Counseling.

[7]  Committee Opinion No. 691: Carrier Screening for Genetic Conditions. , 2017, Obstetrics and gynecology.

[8]  J. Botkin,et al.  Experiences among Women with Positive Prenatal Expanded Carrier Screening Results , 2017, Journal of Genetic Counseling.

[9]  D. Amor,et al.  “I'm Healthy, It's Not Going To Be Me”: Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia , 2016, American journal of medical genetics. Part A.

[10]  L. Finer,et al.  Declines in Unintended Pregnancy in the United States, 2008–2011 , 2016 .

[11]  L. Finer,et al.  Declines in Unintended Pregnancy in the United States, 2008-2011. , 2016, The New England journal of medicine.

[12]  K. Goddard,et al.  “Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening , 2015, Journal of Genetic Counseling.

[13]  I. Haque,et al.  Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels , 2014, PloS one.

[14]  K. Tory,et al.  Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome , 2014, Nature Genetics.

[15]  A. Schapira,et al.  Glucocerebrosidase mutations and the pathogenesis of Parkinson disease , 2013, Annals of medicine.

[16]  L. Ioannou,et al.  ‘No thanks’—reasons why pregnant women declined an offer of cystic fibrosis carrier screening , 2013, Journal of Community Genetics.

[17]  Balaji S. Srinivasan,et al.  An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals , 2012, Genetics in Medicine.

[18]  Prisana Panichkul,et al.  Causes and attitude of husbands toward thalassemic carrier screening test when their partners have abnormal screening tests. , 2012, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[19]  A. Archibald,et al.  Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making , 2011, Journal of Community Genetics.

[20]  T. Prior.  Carrier screening for spinal muscular atrophy , 2008, Genetics in Medicine.

[21]  B. Pletcher,et al.  Carrier screening in individuals of Ashkenazi Jewish descent , 2008, Genetics in Medicine.

[22]  K. Klinger,et al.  Laboratory standards and guidelines for population-based cystic fibrosis carrier screening , 2001, Genetics in Medicine.